NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Five9, Inc. (NASDAQ: FIVN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Five9 caused the company to misrepresent or fail to disclose that: (i) Five9's net new business was not "strong irrespective of the macro" and was, in fact, hampered by macroeconomic issues such as constrained and scrutinized cust ...

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Quantum Corporation, following allegations of financial misrepresentation [1][2]. Group 1: Allegations of Misrepresentation - Quantum Corporation is accused of improperly recognizing revenue during the fiscal year ending March 31, 2025 [2]. - The company will need to restate its previously filed financial statements for the fiscal third quarter ending December 31, 2024, due to these misrepresentations [2]. - Statements regarding Quantum's business, operations, and prospects are claimed to be materially false and misleading, lacking a reasonable basis at all relevant times [2]. Group 2: Shareholder Actions - Shareholders who purchased QMCO shares prior to November 15, 2024, are encouraged to contact Kuehn Law for potential legal action [3]. - Kuehn Law covers all case costs and does not charge investor clients, emphasizing the importance of timely action for shareholders [3].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of LifeMD, Inc. related to misrepresentation of the company's competitive position and financial guidance [1][2]. Group 1: Legal Investigation - Kuehn Law is looking into whether LifeMD's officers and directors have failed in their fiduciary responsibilities to shareholders [1]. - A federal securities lawsuit claims that insiders at LifeMD misrepresented the company's competitive position and failed to disclose rising customer acquisition costs [2]. Group 2: Financial Misrepresentation - LifeMD's competitive position was allegedly overstated, leading to misleading statements about its business and operations [2]. - The lawsuit indicates that the decision to raise LifeMD's 2025 guidance was reckless due to unaccounted rising customer acquisition costs in its RexMD segment and for obesity treatment drugs [2].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Coupang, Inc. related to a federal securities lawsuit concerning inadequate cybersecurity protocols and misrepresentation of information to shareholders [1][2]. Group 1: Cybersecurity Issues - Coupang had inadequate cybersecurity protocols that allowed a former employee to access sensitive customer information for nearly six months without detection [2]. - This breach exposed Coupang to a materially heightened risk of regulatory and legal scrutiny [2]. Group 2: Disclosure Failures - Insiders at Coupang failed to report the data breach in a current report filing with the U.S. Securities and Exchange Commission (SEC), violating applicable reporting rules [2]. - Public statements made by the company were materially false and/or misleading during the relevant times [2].

Group 1 - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of F5, Inc. (NASDAQ: FFIV) [1] - A federal securities lawsuit alleges that F5 insiders misrepresented the company's cybersecurity capabilities while being aware of a security breach in its BIG-IP product development environment [2] - The misrepresentations included claims of best-in-class security offerings up until September 2025, despite knowledge of the breach discovered on August 9, 2025 [2] Group 2 - Shareholders who purchased FFIV shares prior to October 28, 2024, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3] - Kuehn Law covers all case costs and does not charge investor clients, emphasizing the importance of shareholder participation in maintaining market integrity [4]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Avantor, Inc. related to misrepresentation of the company's competitive positioning and operational challenges [1][2]. Group 1: Allegations of Misrepresentation - A federal securities lawsuit claims that insiders at Avantor misrepresented the company's competitive positioning, indicating it was weaker than publicly stated [2]. - The lawsuit also alleges that Avantor faced negative impacts from increased competition, which were not disclosed to shareholders [2]. - As a result of these issues, the representations regarding Avantor's business, operations, and future prospects were deemed materially false and misleading [2]. Group 2: Shareholder Actions - Shareholders who purchased AVTR shares prior to March 5, 2024, are encouraged to contact Kuehn Law for potential legal action, as the firm covers all case costs [3]. - The firm emphasizes the importance of shareholder participation in maintaining the integrity and fairness of financial markets [4].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Inspire Medical Systems, Inc. related to the company's Inspire V product launch [1]. Group 1: Company Performance Issues - The Inspire V launch is reportedly struggling due to low demand, attributed to providers holding excess inventory and disincentives from reduced physician payments [2]. - Critical issues have arisen during the launch, as Inspire failed to complete necessary tasks to support it, including training and onboarding for treatment centers [2]. - The company did not secure required IT approvals for the installation of the SleepSync program at treatment centers, nor did it ensure that claims processing systems and reimbursement codes were ready at launch [2]. - Positive statements made by the company regarding its preparedness and progress for the Inspire V launch have been deemed materially false or misleading [2].

Core Viewpoint - Kuehn Law is investigating potential breaches of fiduciary duties by officers and directors of DeFi Technologies Inc. (NASDAQ: DEFT) towards shareholders [1] Group 1: Legal Investigation - A federal securities lawsuit alleges that insiders at DeFi misrepresented or failed to disclose critical information regarding delays in executing its DeFi arbitrage strategy, which is a key revenue driver [2] - The lawsuit claims that DeFi understated the competition it faced from other DAT companies and the negative impact this competition would have on its business [2] - As a result of these issues, DeFi is unlikely to meet its previously issued revenue guidance, and the true extent of the negative impact on its financial results was downplayed [2] Group 2: Shareholder Action - Shareholders who purchased DEFT prior to May 12, 2025, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3] - Kuehn Law covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder involvement in maintaining market integrity [4]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of ZoomInfo Technologies, Inc. related to misrepresentation of the company's financial and operational results due to the effects of the COVID-19 pandemic [1] Summary by Relevant Sections Financial Misrepresentation - ZoomInfo's financial results were allegedly inflated by temporary demand increases during the COVID-19 pandemic, leading to a misrepresentation of the company's actual performance [1] - The lawsuit claims that ZoomInfo's reported revenues, operating income, and customer retention metrics were materially overstated [1] Customer Base Concerns - A significant portion of ZoomInfo's existing customers were reportedly attempting to reduce their usage or abandon the product altogether [1] - The company allegedly employed manipulative auto-renew policies and threats of litigation to retain customers against their will, damaging customer relationships and competitive advantages [1] Future Implications - The coercive tactics used by ZoomInfo are said to have created a hidden demand cliff for future customer contract renewals, indicating potential challenges in sustaining revenue growth [1]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Fiserv, Inc. related to misleading statements about the company's Payeezy and Clover platforms [1]. Group 1: Allegations Against Fiserv - Insiders at Fiserv allegedly misrepresented issues with the Payeezy platform, forcing merchants to migrate to Clover, which led to unsustainable revenue growth [1]. - Clover's revenue growth was temporarily inflated due to forced conversions from Payeezy, masking a slowdown in new merchant acquisitions [1]. - Following the migration, many former Payeezy merchants reportedly switched to competitors due to Clover's high pricing and poor customer service [1]. - As a result of these merchant losses, Clover's growth in gross payment volume (GPV) and revenue became unsustainable [1]. - Fiserv's positive statements during the Class Period regarding Clover's growth strategies and business prospects were claimed to be materially false and misleading [1].